Daily Archives: 2012/05/31
Dry Eye Disease May Respond to New Topical Treatment
Tofacitinib has an immunomodulatory effect on the ocular surface and may be effective as a therapeutic treatment for dry eye disease.
Medscape Medical News
Medscape Medical News
Streptococcus Endophthalmitis: Doctor, Know Thy Pharmacy
A recent outbreak of streptococcus endophthalmitis after bevacizumab injection in South Florida is a reminder to clinicians to make sure they know what they are injecting and where it came from.
Medscape Medical News
Medscape Medical News
Myopia Protects Against Diabetic Vision Loss
Axial length is behind myopia's protection against diabetic vision problems.
Medscape Medical News
Medscape Medical News
Dear Dr. Wong….
My website reaches people all over the world. I have international and many more national patients as a result of the power of social media. How did this happen?
Cataract Master Learning Simulator Helps Prepare for Real Patients
Massachusetts Eye and Ear Infirmary, a Harvard Medical School affiliate, has released a new system for learning how to perform and deal with the various issues that arise during phacoemulsification cataract surgery. Cataract Master is an interactive simulator that presents students with various real-world scenarios, has them make decisions on the n (Read more...)
Long-term stability of bevacizumab repackaged in 1 mL polypropylene syringes for intravitreal administration
Source: Annales Pharmaceutiques Francaises
Area: Evidence > Medicines Management > References
Introduction: The anti-angiogenic monoclonal antibody, bevacizumab, is currently used by intravitreal administration as an off-label drug to treat age-related macular degeneration or other ophthalmological diseases. For this purpose, commercial bevacizumab is repackaged in 1mL polypropylene syringes under sterile conditions. However, no complete study on the stability of this hospital-based preparation is available. Methods: Commercial bevacizumab (25 mg/mL; Avastin) was aseptically repackaged in 1 mL polypropylene syringes, stored at 4C, and analysed on the day of preparation (D0), and after 30 days (D30) and 90 days (D90). Some syringes were kept for up to 8 months to observe possible instability. Several complementary and stability-indicating analytical methods were used to assess in detail the primary, secondary and tertiary structure of the antibody during storage: ionic chromatography, size-exclusion chromatography, peptide mapping, 2nd ...
Area: Evidence > Medicines Management > References
Introduction: The anti-angiogenic monoclonal antibody, bevacizumab, is currently used by intravitreal administration as an off-label drug to treat age-related macular degeneration or other ophthalmological diseases. For this purpose, commercial bevacizumab is repackaged in 1mL polypropylene syringes under sterile conditions. However, no complete study on the stability of this hospital-based preparation is available. Methods: Commercial bevacizumab (25 mg/mL; Avastin) was aseptically repackaged in 1 mL polypropylene syringes, stored at 4C, and analysed on the day of preparation (D0), and after 30 days (D30) and 90 days (D90). Some syringes were kept for up to 8 months to observe possible instability. Several complementary and stability-indicating analytical methods were used to assess in detail the primary, secondary and tertiary structure of the antibody during storage: ionic chromatography, size-exclusion chromatography, peptide mapping, 2nd ...
Mayo Clinic offers new technology for treatment of dry eye
Mayo Clinic in Arizona is the first medical center in Arizona and the Southwest to provide a new technology that treats dry eye by targeting blocked eyelid glands. Blocked glands can inhibit production of oil that is necessary for healthy tears needed to lubricate the eyes.
Age-Related Vision Loss Prevented By Fish Oil
An omega-3 fatty acid found in fish, known as DHA, prevented age-related vision loss in lab tests, demonstrates recently published medical research from the University of Alberta. Faculty of Medicine & Dentistry researcher Yves Sauve and his team discovered lab models fed DHA did not accumulate a toxic molecule at the back of the eyes...
DHA prevents age-related vision loss in lab tests
An omega-3 fatty acid found in fish, known as DHA, prevented age-related vision loss in lab tests, demonstrates recently published medical research from the University of Alberta.
Subscribe
